🇺🇸 FDA

Company profile · Sponsor

Shanghai

Shanghai Chest Hospital

C43F7B1 · NMPA pharma CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

Shanghai (C43F7B1) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C43F7B1
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (3)

Search pipeline →

  1. PD-1inhibitor

    Shanghai

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  2. neoadjuvant anti-PD-1

    Shanghai

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  3. two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel

    Shanghai

    NSCLC

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Shanghai?

Shanghai (C43F7B1) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Shanghai sponsor?

We track 3 ClinicalTrials.gov-linked programs for Shanghai, including PD-1inhibitor and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Shanghai company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.